New Oxoid Chromogenic Medium Improves Screening For MRSA
Main Category: MRSA / Drug ResistanceArticle Date: 29 Nov 2005 - 0:00 PDT
| Patient / Public: | ![]() |
3 (4 votes) |
| Healthcare Prof: | ![]() |
3.7 (10 votes) |
Oxoid Limited has expanded its range of products for the growth and identification of methicillin resistant Staphylococcus aureus (MRSA) with the addition of a new Chromogenic Medium for screening of MRSA. Oxoid Chromogenic MRSA Agar (product code:P01091A UK/PO5083A other) has been specifically designed to screen clinical samples for the presence of MRSA, providing accurate, easy to read results in as little as 18 hours - up to 30 hours quicker than some alternative media that may require 48 hour incubations. There is no need to re-incubate negative plates, making it a true next-day test.
Fast and accurate screening is extremely important for infection control programmes to be effective. The speed of detection using Oxoid Chromogenic MRSA Agar allows colonised patients to be targeted promptly for isolation and appropriate treatment, helping to minimise opportunities for transmission at the earliest opportunity. The accuracy of the new Oxoid medium helps to ensure that costly resources are targeted towards those who need it, especially in hospitals where the MRSA rate is high.
The chromogen in Oxoid Chromogenic MRSA Agar detects phosphatase activity, which is present in MRSA strains, producing distinct, easily visible, denim-blue colonies. Antimicrobial compounds within the medium, including cefoxitin, inhibit the growth of competitor organisms to allow accurate diagnosis of MRSA.
The medium may be inoculated directly from swabs, or from isolates or culture suspensions. The plate can then be examined for MRSA colonies after a short, 18-hour incubation.
In a comparative evaluation with four other commercially available chromogenic media and Oxacillin Resistance Screening Agar (ORSA), the Oxoid Chromogenic MRSA Agar produced the best results at 18 hours and gave excellent colour differentiation1.
For further information about Oxoid Chromogenic MRSA Agar, please telephone +44 (0)1256 841144, email val.kane@oxoid.com or visit http://www.oxoid.com
References:
1 Hutchinson, M. J., Edwards, G. F. S., Morrison, D., "Evaluation of chromogenic MRSA selective screening media," poster by Scottish MRSA Reference Laboratory presented at the 2005 Institute of BioMedical Sciences Annual Conference.
http://www.oxoid.com
Visit our mrsa / drug resistance section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/34212.php>
APA
http://www.medicalnewstoday.com/releases/34212.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




